Oral semaglutide shows promising results for type 2 diabetes in routine clinical settings Post author: Post published:May 28, 2024 Post category:uncategorized Semaglutide and its effects on glycemic control, body weight (BW), and tolerability in routine clinical practice. You Might Also Like Novel gene therapy holds potential in treating patients with epilepsy October 9, 2024 Harnessing the power of gamers to solve cancer’s mysteries January 23, 2025 Evaluating CGM accuracy and benefits in non-diabetic populations June 27, 2024